Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Don’t Panic. Apple Inc. Stock Has No Upside from a Netflix Acquisition

By James Brumley, InvestorPlace Feature Writer
Apple stock holders need not worry about the company wasting money buying Netflix. There's no benefit -- direct or indirect -- in doing so, and Apple knows it.

3 Reasons to Be Bullish on Coca-Cola Co Stock

By Tom Taulli, InvestorPlace Contributor
Coca-Cola has posted meager returns for the past decade. The company has had to fight negative secular trends, such as the move towards healthier diets. But going forward, there are encouraging signs that the shares will get back on track.

FDA Win Sends Celsion Corporation (CLSN) Shares Higher

By Karl Utermohlen, InvestorPlace Writer
Celsion (CLSN) shares were up Thursday as the company received FDA clearance on its plans to start a Phase I/II clinical trial of OVATION II.

10 Startups to Watch in 2018

By Regina Borsellino
Everyone knows the big companies, but what 2018 startups should you keep an eye on? Today's small startup could be tomorrow's technology giant.

Virtual Reality Will Propel Sony Corp (ADR) Stock Price Higher!

By Bret Kenwell, InvestorPlace Contributor
Sony gained momentum with its PlayStation virtual reality headset (PSVR) over the holidays, which bodes well for the SNE stock price.

Taco Bell Dollar Menu Debuts $1 Nacho Fries

By Karl Utermohlen, InvestorPlace Writer
Taco Bell is expanding its Dollar Menu offerings with a $1 Nacho Fries portion that's ideal for those looking for a cheap and yummy snack.

Macy’s Stores Closing 2018: The Updated List

By William White, InvestorPlace Writer
An updated list of the Macy's stores closing in 2018 has been released and the chain will be shutting down 11 locations early this year.

Merrill Lynch Bans Trading in Bitcoin-Related Products

By William White, InvestorPlace Writer
Bank of America's (BAC) Merrill Lynch is no longer allowing trading in products connected to bitcoin due to concerns about it.

Best Diets for 2018: U.S. News Releases Annual Ranking

By Karl Utermohlen, InvestorPlace Writer
The list of the best diets for 2018 has been unveiled by the U.S. News & World Report and the Mediterranean Diet has been ranked number one.

Sprint Corp Names Michael Combes as President & CFO

By William White, InvestorPlace Writer
Sprint (S) has named Michael Combes as its next President and CFO and it hopes his experience will help with its transformation plans.

Apple’s Battery Replacement Program Could Cost It $10 Billion

By Brad Moon, InvestorPlace Contributor
Customers opting for a $29 replacement battery over a new iPhone could lose Apple up to 16 million iPhone sales in 2018.

Why Ambev SA (ADR) Stock Could Triple Its Dividend

By Lawrence Meyers, InvestorPlace Contributor
With the Brazil economy improving and solid cash flow, Ambev can raise its dividend, and Ambev stock could double from here.

Sprint’s CFO Change Is Only the Beginning of Its Terrible Year

By Vince Martin, InvestorPlace Contributor
Sprint stock is plunging lower on a CFO change, and without a catalyst on the horizon it looks like S stock has a tough year ahead of it.

Australia Plans for Medicinal Marijuana Exports

By William White, InvestorPlace Writer
Australia is planning to legalize medicinal marijuana exports, which will make it the fourth country in the world to do so.

Zynga (ZNGA) a Buy on Robust Earnings Visibility

By Portfolio Grader
Currently, Zynga Inc (NASDAQ:ZNGA) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking ZNGA has had from Portfolio Grader for 6 months.

Earnings Momentum Keep Valeant Pharmaceuticals International (VRX) a Buy

By Portfolio Grader
Valeant Pharmaceuticals International Inc (NYSE:VRX) ranks in the top 25% of its industry group, Pharmaceuticals, and in the top 25% of its sector group, Health Care, with a market value of $7.2 billion. From an investment attractiveness viewpoint, VRX is ranked in the top quartile of the sector with a ranking of 148 among the 779 companies in the sector; the stock's Portfolio Grader ranking places it 21 among the 134 companies in this industry group, giving it a well above-average position and number 871 in the 5000 company Portfolio Grader company universe.

Flagging Quant Score Make Teva Pharmaceutical Industries (TEVA) a Sell

By Portfolio Grader
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is one of 134 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 779 company GICS Health Care sector. The market value of TEVA is $19.3 billion which falls in the top quarter of its industry group. The current Portfolio Grader ranking for TEVA puts it 117 among the 134 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 680 among the 779 companies in the sector, and number 4,039 in the nearly 5,000 company Portfolio Grader universe.

Enough With the Excuses! Tesla Needs a New Magic Trick

By Dana Blankenhorn, InvestorPlace Contributor
Tesla is failing to meet its production scaling problems, but CEO Elon Musk has other tricks, including trucks, up his sleeve.

Why Coffee Lake Matters for Intel Corporation Stock

By Chris Lau, InvestorPlace Contributor
Intel is actively refreshing its CPU lineup to catch up to AMD. As the company continues to grow revenues, Intel stock still has more upside.
Load More Articles